Davide Grandolfo

Davide Grandolfo is a research expert specializing in cell therapy, currently working at Evotec since April 2022. With prior experience as a Principal Scientist at Merck Italia and roles in analytical development at Cell and Gene Therapy Catapult, Davide has a strong background in immunology. His expertise was further developed during a postdoctoral fellowship at Université de Genève and a PhD in immunology from Imperial College London, where research focused on immune responses and lung inflammation. Additional experience includes work as a biomedical technician at Paediatric Hospital Bambino Gesù and significant contributions to respiratory research at Philip Morris International, including the use of 3D cell culture methods.